Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Other Current Assets
Entera Bio Ltd
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Other Current Assets
$238k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Other Current Assets
$241k
|
CAGR 3-Years
189%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Other Current Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Other Current Assets
$1m
|
CAGR 3-Years
90%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Other Current Assets
$11.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Other Current Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Entera Bio Ltd's Other Current Assets?
Other Current Assets
238k
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Other Current Assets amounts to 238k USD.
What is Entera Bio Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
2%
Over the last year, the Other Current Assets growth was -18%. The average annual Other Current Assets growth rates for Entera Bio Ltd have been -3% over the past three years , 2% over the past five years .